The Future of the Modern Laboratory Is Here: Introducing Mivado GlobalPerformance’s AI-Driven LIMS – In today’s fast-paced scientific and industrial landscape, laboratories are under more pressure than ever to deliver faster results and maintain airtight compliance.
Risk Evaluation in Biopharmaceutical Technology Transfer: Why a Risk-Based Approach Is Essential for GMP Success. Successful biopharmaceutical technology transfer depends on more than process knowledge.
Drafting Perfect 483 Responses: The New FDA Guidelines Explained. FDA Form 483 observations are issued when investigators identify conditions that may violate cGMP requirements.
Beyond Documentation: Solving the Tacit Knowledge Gap in Pharmaceutical Tech Transfer: This article discuss why Your Documentation Is Not Enough and How to Institutionalize Expert Know-How. Visit us for more…
The Algorithm of Biopharma Compliance in Canada : Navigating Health Canada’s AI Regulatory Shift In the fast-evolving landscape of Canadian life sciences where “innovation” is no longer just about the molecule. It’s about the machine.
